Clustering of Risk Factors: A Simple Method of Detecting Cardiovascular Disease in Youth

OBJECTIVE: Cardiovascular risk assessment is an accepted practice in adults and correlates with early changes in carotid structure and function. Its clinical use in pediatrics is less common. We sought to determine whether a simple method of clustering cardiovascular risks could detect early atherosclerotic changes in youth. In addition, we compared risk clustering with the accepted Patholobiological Determinants of Atherosclerosis in Youth score to assess its utility for predicting early vascular disease. PATIENTS AND METHODS: We collected demographic, anthropometric, laboratory, and vascular measures in a cross-sectional study. The study population (n = 474; mean age: 18 years) was divided into low-risk (0–1) or high-risk (≥2) groups on the basis of the number of cardiovascular risk factors present at evaluation. Group differences and vascular outcomes were compared. General linear models were used to compare clustering cardiovascular risks with the Patholobiological Determinants of Atherosclerosis in Youth score. RESULTS: The high-risk group had higher vascular thickness and stiffness compared with the low-risk group (P < .05). Regression models found that clustering cardiovascular risks is associated with abnormal vascular structure and function after adjustment for age, race, and gender. The Patholobiological Determinants of Atherosclerosis in Youth score also is associated with abnormal vascular structure and function but with lower R2 values (P < .05). CONCLUSIONS: Cardiovascular risk clustering is a reliable tool for assessing abnormal vascular function. Its simplicity, compared with the Patholobiological Determinants of Atherosclerosis in Youth score, provides an advantageous tool for the practicing clinician to identify those youth who are at higher risk for early cardiovascular disease.

[1]  Gerald S. Berenson,et al.  Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa heart study , 1986 .

[2]  Zahi A Fayad,et al.  Risk scores predict atherosclerotic lesions in young people. , 2005, Archives of internal medicine.

[3]  J. Dawson,et al.  Carotid Intimal-Medial Thickness Is Related to Cardiovascular Risk Factors Measured From Childhood Through Middle Age: The Muscatine Study , 2001, Circulation.

[4]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[5]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[6]  B. Neal The Blood Pressure Lowering Treatment Trialists' Collaboration , 2001 .

[7]  G. Mensah,et al.  Major coronary risk factors and death from coronary heart disease: baseline and follow-up mortality data from the Second National Health and Nutrition Examination Survey (NHANES II). , 2005, American journal of preventive medicine.

[8]  National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents , 2004, Pediatrics.

[9]  Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.

[10]  R. Tracy,et al.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. , 1998, The New England journal of medicine.

[11]  H. Struijker‐Boudier,et al.  Expert consensus document on arterial stiffness: methodological issues and clinical applications. , 2006, European heart journal.

[12]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .

[13]  J. Strong,et al.  PDAY risk score predicts advanced coronary artery atherosclerosis in middle-aged persons as well as youth. , 2007, Atherosclerosis.

[14]  B Neal,et al.  Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials , 2000, The Lancet.

[15]  S. Daniels,et al.  Youth With Obesity and Obesity-Related Type 2 Diabetes Mellitus Demonstrate Abnormalities in Carotid Structure and Function , 2009, Circulation.

[16]  S. Gidding,et al.  Preventing Heart Disease in the 21st Century: Implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study , 2008, Circulation.

[17]  W. Kannel,et al.  Contributions of the Framingham Study to the conquest of coronary artery disease. , 1988, The American journal of cardiology.

[18]  B. Rosner,et al.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents , 2004 .

[19]  P Hjemdahl,et al.  Biochemical assessment of sympathetic activity and prejunctional modulation of noradrenaline release in humans. , 1996, Journal of hypertension.

[20]  V. Basevi Standards of Medical Care in Diabetes—2010 , 2010, Diabetes Care.

[21]  M. O'Rourke,et al.  Pulse wave analysis. , 2001, British journal of clinical pharmacology.

[22]  J. Slattery,et al.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.

[23]  S. Kashyap,et al.  THE NATURAL HISTORY OF CORONARY ATHEROSCLEROSIS. , 1964, Diseases of the chest.

[24]  Mika Kähönen,et al.  Association of Pathobiologic Determinants of Atherosclerosis in Youth risk score and 15-year change in risk score with carotid artery intima-media thickness in young adults (from the Cardiovascular Risk in Young Finns Study). , 2007, The American journal of cardiology.

[25]  B. Fagerberg,et al.  Carotid artery intima‐media thickness in patients with Type 2 diabetes mellitus and impaired glucose tolerance: a systematic review , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[26]  Amy S. Shah,et al.  Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. , 2009, The Journal of clinical endocrinology and metabolism.

[27]  Eric J Topol,et al.  Prevalence of conventional risk factors in patients with coronary heart disease. , 2003, JAMA.

[28]  J. Strong,et al.  Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[29]  J. Stengård,et al.  Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.

[30]  M. O'Rourke,et al.  Pulse wave analysis. , 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.